Page results
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
Information for patients having a surgery via median sternotomy.
-
Information for patients having a mediastinoscopy / mediastinotomy procedure.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
Court of Appeal has ruled in favour of the Tavistock and Portman NHS Trust, which leads the national Gender Identity and Development Service (GIDS).
File results
-
FOI2017126 Staff infected by blood-borne virus by patients
-
FOI2017125 Restraint of patients
-
FOI2017123 Information on the price paid, total expenditure and total volume held of Cyanide antidotes, Levothyroxine and Primidone medications
-
Charity Matters magazine - Winter 2020
-
FOI201790 Complementary and Alternative Medicine Library and Information Service refurbishment
-
FOI2017119 Diagnosis and treatment of Alzheimer disease patients
-
FOI2017107 Number of physical attacks on staff, patients and visitors
-
FOI201795 Patient administration system
-
FOI201796 IT middle management organisational structure
-
FOI2017129 Water hygiene